U.S. Securities and Exchange Commission v. C3 International, Inc.

CourtDistrict Court, C.D. California
DecidedNovember 7, 2022
Docket8:21-cv-01586
StatusUnknown

This text of U.S. Securities and Exchange Commission v. C3 International, Inc. (U.S. Securities and Exchange Commission v. C3 International, Inc.) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
U.S. Securities and Exchange Commission v. C3 International, Inc., (C.D. Cal. 2022).

Opinion

Case 8:21-cv-01586-CAS-PD Document 39 Filed 11/07/22 Pagel1of15 Page ID #:206 UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA CIVIL MINUTES —- GENERAL ‘O’ Case No. 8:21-CV-01586-CAS (PDx) Date November 7, 2022 Title U.S. SECURITIES AND EXCHANGE COMMISSION v. C3 INTERNATIONAL, INC., ET AL.

Ss ee eee CHRISTINA A_SNYDER Catherine Jeang Not Present N/A Deputy Clerk Court Reporter / Recorder Tape No. Attorneys Present for Plaintiffs: Attorneys Present for Defendants: Not Present Not Present Proceedings: (IN CHAMBERS) - MOTION FOR DEFAULT JUDGMENT (Dkt. 21, filed on May 11, 2022) I. INTRODUCTION On September 28, 2021, plaintiff United States Securities and Exchange Commission (“SEC”) filed this action against defendants C3 International, Inc., (“C3”), Steele Clark Smith III (“Steele Smith”), and Theresa Smith (collectively, “defendants”). Dkt. 1 (“Compl.”). The complaint brings five claims for relief: (1) Fraud in Connection with the Purchase or Sale of Securities, in violation of Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”), 15 U.S.C. § 78)(b), and Rule 10b-5 thereunder, 17 C_F.R. § 240.10b-5 (against C3 and Steele Smith); (2) Fraud in the Offer or Sale of Securities in violation of Sections 17(a)(1), (2), and (3) of the Securities Act of 1933 (“Securities Act’), 15 U.S.C. §77(q)(a) (against C3 and Steele Smith); (3) Aiding and Abetting Violations of Section 17(a) of the Securities Act (against Theresa Smith): (4) Aiding and Abetting Violations of Section 10(b) of the Exchange Act and Rule 10b-5 thereunder (against Theresa Smith); and (5) Unregistered Offer and Sale of Securities Violations of Sections 5(a) and 5(c) of the Securities Act (against all defendants). Id. 66-75. On January 7, 2022, after having received no response or answer from defendants, the SEC requested the Clerk of the Court enter default against defendants pursuant to Federal Rule of Civil Procedure (“Rule”) 55(a). Fed. R. Civ. P. 55(a). Dkt. 17. Pursuant to the SEC’s request, the Clerk entered default on January 7, 2022. Dkt. 18 (“Entry of Default’).

Case 8:21-cv-01586-CAS-PD Document 39 Filed 11/07/22 Page2of15 Page ID #:207 UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA CIVIL MINUTES —- GENERAL ‘O’ Case No. 8:21-CV-01586-CAS (PDx) Date November 7, 2022 Title U.S. SECURITIES AND EXCHANGE COMMISSION v. C3 INTERNATIONAL, INC., ET AL. On March 24, 2022, the Court ordered the SEC to show cause as to why this action should not be dismissed for lack of prosecution. Dkt. 19. On March 29, 2022, the SEC filed aresponse. Dkt. 20 (“Response”). On May 11, 2022, the SEC filed the instant motion for default judgment. Dkt. 21 (“MDJ’). On July 11, 2022, the Court held a hearing. Counsel Derek S. Bensten and Stephen T. Kaiser appeared on behalf of plaintiff SEC. Defendants Steele Clark Smith, III and Theresa Smith (the “Smith defendants”) appeared on behalf of themselves. During the hearing, the Smith defendants requested time to contest the SEC’s motion for default judgment and to obtain counsel. The Court withheld entering default judgment contingent on the defendants filing responsive pleadings. Dkt. 25. On September 4, 2022, the Smith defendants filed a memorandum in opposition to the plaintiff's motion for default judgment that denies the factual allegations in plaintiff's complaint. Dkt. 27. On September 9, 2022, the Court acknowledged receipt of the Smith defendants’ “answer” and directed it be lodged as a “responsive pleading.” Dkt. 29. The Court then directed defendants to file a brief setting forth why entry should be put aside. Id. On September 30, 2022, the Smith defendants filed their supplemental memorandum. Dkts. 33, 36-1. On October 7, 2022, plaintiff filed a reply restating its request for default judgment as to all three defendants. Dkt. 37. On October 26, 2022, the Smith defendants filed a “further supplemental memorandum” in opposition to plaintiff's motion for default judgment. Dkt. 38. To date, C3, as a corporate entity, has not appeared or responded in any way. Having carefully considered the parties’ arguments and submissions, the Court finds and concludes as follows. II. BACKGROUND Defendant C3 is a private, California-based corporation, formed in November 2011, with its purported principal place of business in Garden Grove, California. Id. §

CV-90 (10/18) CIVIL MINUTES - GENERAL Page 2 of 15

Case 8:21-cv-01586-CAS-PD Document 39 Filed 11/07/22 Page3of15 Page ID #:208 UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA CIVIL MINUTES —- GENERAL ‘O’ Case No. 8:21-CV-01586-CAS (PDx) Date November 7, 2022 Title U.S. SECURITIES AND EXCHANGE COMMISSION v. C3 INTERNATIONAL, INC., ET AL. 10. Defendant Steele Smith is a current resident of Garden Grove, California, and is listed as the CEO, Secretary, CFO, and Director of C3, according to the certificate filed with the California Secretary of State. Id. 11. Defendant Theresa Smith, wife of Steele Smith, is a current resident of Garden Grove, California, and is the co-founder and President of C3. Id. § 12. Additionally, in October 2010, Steele Smith and Theresa Smith formed the related entity C3 Patients Association (“C3PA”), a nonprofit member association organized for the purpose of providing members with medical marijuana. From approximately 2010 to 2015, C3PA sold cannabis products and billed insurance companies for rembursement. Id. § 13. The SEC’s complaint alleges that from approximately October 2011 through November 2019, defendants raised approximately 2 million dollars from more than 40 investors by selling stock in C3 through Steele Smith’s material misrepresentations and omissions regarding the company’s business and its cannabis pill called Idrasil. Compl. § 5. C3’s website claims that Idrasil was either patented or patent pending, but Steele Smith had only filed a provisional patent application. Id. J 18-21. Steele Smith and C3 stated in business summaries that C3 would use investment proceeds for business purposes, but Steele Smith and Theresa Smith diverted a substantial portion of those proceeds for their personal living expenses. Id. {J 25-28. Steele Smith and C3 made statements disclosing Steele Smith’s background and history but omitted that he was a convicted felon; he was convicted of conspiracy to manufacture at least 1000 marijuana plants in 2012 in United States v. Smith, 8:07-cr-00264-CJC (C.D. Cal.). Compl. § 30- 31. Moreover, the complaint alleges that Steele Smith and C3 represented that Idrasil was reimbursable by most health insurance companies in California, but fewer than half of insurance companies accepted Idrasil for payment. Id. 4] 32-33. Further, Steele Smith and C3 represented that pharmaceutical companies had shown interest in purchasing C3 and that C3 would, according to Smith’s financial projections, achieve at least $4.6 million in gross revenue the next year. However, no big pharmaceutical companies had responded to Steele Smith and C3PA had never made more than $57,000 in a single year from Idrasil. Id. | 36-40. When questioned by investors about when they would receive money from C3, Steele Smith represented that C3 had a building in escrow and that as soon as the deal closed, he would have the funds to buy out the investors. However C3

CV-90 (10/18) CIVIL MINUTES - GENERAL Page 3 of 15

Case 8:21-cv-01586-CAS-PD Document 39 Filed 11/07/22 Page 4of15 Page ID #:209 UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA CIVIL MINUTES —- GENERAL ‘O’ Case No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

TSC Industries, Inc. v. Northway, Inc.
426 U.S. 438 (Supreme Court, 1976)
SEC v. Platforms Wireless Intern. Corp.
617 F.3d 1072 (Ninth Circuit, 2010)
Jose Luis Pena v. Seguros La Comercial, S.A.
770 F.2d 811 (Ninth Circuit, 1985)
Gary R. Eitel v. William D. McCool
782 F.2d 1470 (Ninth Circuit, 1986)
Securities and Exchange Commission v. Maurice Rind
991 F.2d 1486 (Ninth Circuit, 1993)
SEC v. Phan
500 F.3d 895 (Ninth Circuit, 2007)
Securities & Exchange Commission v. Moran
944 F. Supp. 286 (S.D. New York, 1996)
Pepsico, Inc. v. California Security Cans
238 F. Supp. 2d 1172 (C.D. California, 2002)
Liu v. SEC. & Exch. Comm'n
591 U.S. 71 (Supreme Court, 2020)
HTS, Inc. v. Boley
954 F. Supp. 2d 927 (D. Arizona, 2013)
Philip Morris USA Inc. v. Castworld Products, Inc.
219 F.R.D. 494 (C.D. California, 2003)
Elektra Entertainment Group Inc. v. Crawford
226 F.R.D. 388 (C.D. California, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
U.S. Securities and Exchange Commission v. C3 International, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/us-securities-and-exchange-commission-v-c3-international-inc-cacd-2022.